Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Realty Income Corp (O) Price & Performance

AbCellera Biologics IncTrade
Realty Income CorpTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Realty Income Corp — how do they compare? AbCellera Biologics Inc trades at $8.96 (market cap $2.99B), while Realty Income Corp trades at $61.94 (market cap $58.56B). The key difference: Realty Income Corp is far larger — about 19.6× AbCellera Biologics Inc's market cap, and Realty Income Corp pays a 5.25% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLO
Market Cap
$2.99B$58.56B
Sector
HealthReal Estate
52-Week High
$9.76$67.56
52-Week Low
$2.78$55.93
Enterprise Value
$2.58B$89.19B
Dividend Yield
5.25%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Realty Income Corp

Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.

Read more on O